69 results on '"Reincke, Martin"'
Search Results
2. Moderate salt restriction in primary aldosteronism improves bone metabolism through attenuation of urinary calcium and phosphate losses
3. Screening for Primary Aldosteronism by Mass Spectrometry Versus Immunoassay Measurements of Aldosterone: A Prospective Within-Patient Study
4. Postoperative ACTH-stimulated aldosterone predicts biochemical outcome in primary aldosteronism
5. Responses to systemic therapy in metastatic pheochromocytoma/paraganglioma - A retrospective multi-center cohort study
6. Bilateral inferior petrosal sinus sampling with human CRH stimulation in ACTH-dependent Cushing's syndrome: results from a retrospective multicenter study
7. Glucocorticoid receptor polymorphism BclI with increased glucocorticoid sensitivity has a positive influence on quality of life in endogenous Cushing's syndrome in remission
8. Low-grade inflammation during the glucocorticoid withdrawal phase in patients with Cushing's syndrome
9. Cushing’s Syndrome in the Elderly: Data from the European Registry on Cushing’s Syndrome
10. Lack of sensitivity of diagnostic Cushing-scores in Germany: a multicenter validation
11. In Situ Metabolomics of Cortisol-Producing Adenomas
12. 11-Oxygenated androgens are not secreted by the human ovary: in-vivo data from four different cases of hyperandrogenism
13. 11-Oxygenated C19 steroids are the predominant androgens responsible for hyperandrogenemia in Cushing's disease
14. Influence of cortisol cosecretion on non-ACTH-stimulated adrenal venous sampling in primary aldosteronism: a retrospective cohort study
15. Aggressive pituitary tumours and carcinomas, characteristics and management of 171 patients
16. The metabolic phenotype of patients with primary aldosteronism: impact of subtype and sex – a multicenter-study of 3566 Caucasian and Asian subjects
17. True unilateral primary aldosteronism exists, and unilateral adrenalectomy saves lives
18. Identification of predictive criteria for pathogenic variants of primary bilateral macronodular adrenal hyperplasia (PBMAH) gene ARMC5 in 352 unselected patients
19. Identification of glucocorticoid-related molecular signature by whole blood methylome analysis
20. Renin, a marker for left ventricular hypertrophy, in primary aldosteronism: a cohort study
21. Mass spectrometry imaging identifies metabolic patterns associated with malignant potential in pheochromocytoma and paraganglioma
22. Patients with low IGF-I after curative surgery for Cushing’s syndrome have an adverse long-term outcome of hypercortisolism-induced myopathy
23. Drug-resistant hypertension in primary aldosteronism patients undergoing adrenal vein sampling: the AVIS-2-RH study
24. Corticotroph tumor progression after bilateral adrenalectomy (Nelson’s syndrome): systematic review and expert consensus recommendations
25. Prospective evaluation of aldosterone LC-MS/MS-specific cutoffs for the saline infusion test
26. ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of Cushing's syndrome
27. Metabolic impact of pheochromocytoma/paraganglioma: targeted metabolomics in patients before and after tumor removal
28. High mortality within 90 days of diagnosis in patients with Cushing’s syndrome: results from the ERCUSYN registry
29. THERAPY OF ENDOCRINE DISEASE: Medical treatment of primary aldosteronism
30. Driver mutations in USP8 wild-type Cushing’s disease
31. Surviving ectopic Cushing’s syndrome: quality of life, cardiovascular and metabolic outcomes in comparison to Cushing’s disease during long-term follow-up
32. MANAGEMENT OF ENDOCRINE DISEASE: Diagnosis and management of primary aldosteronism: the Endocrine Society guideline 2016 revisited
33. Primary aldosteronism: key characteristics at diagnosis: a trend toward milder forms
34. Preoperative medical treatment in Cushing’s syndrome: frequency of use and its impact on postoperative assessment: data from ERCUSYN
35. Plasma Steroid Metabolome Profiling for Diagnosis and Subtyping Patients with Cushing Syndrome
36. Treatment of aggressive pituitary tumours and carcinomas: results of a European Society of Endocrinology (ESE) survey 2016
37. Somatic USP8 mutations are frequent events in corticotroph tumor progression causing Nelson’s tumor
38. DIAGNOSIS OF ENDOCRINE DISEASE: 18-Oxocortisol and 18-hydroxycortisol: is there clinical utility of these steroids?
39. Cortisol-related metabolic alterations assessed by mass spectrometry assay in patients with Cushing's syndrome
40. Scalp hair cortisol for diagnosis of Cushing’s syndrome
41. Persistence of myopathy in Cushing’s syndrome: evaluation of the German Cushing’s Registry
42. Landscape of somatic mutations in sporadic GH-secreting pituitary adenomas
43. Mass Spectrometry–Based Adrenal and Peripheral Venous Steroid Profiling for Subtyping Primary Aldosteronism
44. Life-threatening events in patients with pheochromocytoma
45. Increased prevalence of diabetes mellitus and the metabolic syndrome in patients with primary aldosteronism of the German Conn's Registry
46. A critical reappraisal of bilateral adrenalectomy for ACTH-dependent Cushing's syndrome
47. Subclinical hypercortisolism: a state, a syndrome, or a disease?
48. Decoding the genetic basis of Cushing's disease: USP8 in the spotlight
49. ACTH after 15 min distinguishes between Cushing's disease and ectopic Cushing's syndrome: a proposal for a short and simple CRH test
50. THERAPY OF ENDOCRINE DISEASE: Outcomes in patients with Cushing's disease undergoing transsphenoidal surgery: systematic review assessing criteria used to define remission and recurrence
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.